Skip to main content
logo
Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.010
+0.019 (1.91%)
Oct 14, 2026, 11:48 AM EDT - Market open

Werewolf Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
49316614063328
Market Cap Growth
-34.15%-53.38%-52.79%121.66%-80.81%-
Enterprise Value
272-2062-62160
Last Close Price
0.990.631.483.862.0511.91

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.34-34.997.013.84-
PB Ratio
2.961.240.901.250.522.15
P/TBV Ratio
3.011.240.901.250.522.15

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1.29--3.10--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.520.510.470.120.10
Net Debt / Equity Ratio
-1.35-0.78-1.01-0.74-0.94-0.93
Net Debt / EBITDA Ratio
1.000.331.032.132.092.85
Net Debt / FCF Ratio
0.730.321.312.472.593.27
Asset Turnover
0.36-0.010.120.10-
Quick Ratio
2.801.587.317.005.6813.27
Current Ratio
2.911.627.457.145.8413.57
Return on Equity (ROE)
-119.86%-123.88%-76.33%-31.98%-39.12%-41.31%
Return on Assets (ROA)
-27.39%-38.63%-30.48%-15.11%-20.64%-22.71%
Return on Capital Employed (ROCE)
-157.00%-182.50%-65.90%-26.10%-41.10%-29.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-70.52%-197.79%-106.92%-26.75%-85.38%-15.22%
FCF Yield
-61.42%-196.07%-85.58%-23.89%-70.14%-13.21%
Buyback Yield / Dilution
-7.56%-6.73%-23.04%-23.50%-56.40%-1736.32%
SEC Filings: 10-K · 10-Q